Switch to:
More From Other Websites
InPlay from Briefing.com Apr 28 2017
Genzyme, CHC lift Sanofi's first-quarter figures, upbeat on Dupixent Apr 28 2017
Regeneron and Sanofi Announce Kevzara® (sarilumab) Biologics License Application Resubmission... Apr 28 2017
Amgen's Q1 Results Highlight the Need for an Acquisition Apr 27 2017
Dupixent Expected to Be a Solid Addition to Regeneron’s Portfolio Apr 27 2017
Analysts’ Recommendations for Regeneron in 1Q17 Apr 27 2017
Amgen Trips Amid Rivals: Sales Miss By $100 Million, But Earnings Top Apr 26 2017
Will Regeneron’s Revenue Surpass Analysts’ Estimates in 1Q17? Apr 26 2017
Will Amgen's Rivals Pop On Its Cholesterol-Busting Drug? Apr 26 2017
Earnings Preview: What To Expect From Amgen On Wednesday Apr 25 2017
Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent®... Apr 25 2017
Regeneron and Sanofi Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent®... Apr 25 2017
Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara® (sarilumab) to Treat Adult Patients... Apr 24 2017
Amgen Trumps Regeneron, Sanofi In Cholesterol Drug Sales Apr 21 2017
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug Apr 21 2017
Sanofi Genzyme hit with patent lawsuit over new eczema drug Apr 20 2017
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain Apr 17 2017
3 Big Reasons to Be Bullish on Biotech Stocks Apr 16 2017
[$$] As Drug Prices Fall, These Stocks Could Rise Apr 14 2017
Regeneron to Report First Quarter 2017 Financial and Operating Results and Host Conference Call and... Apr 14 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK